Lloyd K C, Stover S M, Pascoe J R, Baggot J D, Kurpershoek C, Hietala S
Veterinary Medical Teaching Hospital, School of Veterinary Medicine, University of California, Davis 95616.
Am J Vet Res. 1988 May;49(5):644-9.
The concentration of gentamicin in plasma and synovial fluid of normal adult horses was measured periodically for 24 hours after IV (2.2 mg/kg of body weight), intra-articular (IA; 150 mg), and simultaneous IV and IA administrations. Gentamicin also was buffered with sodium bicarbonate (3 mEq) and then was administered IA and simultaneously IV and IA. Synovial fluid specimens were obtained via an indwelling catheter placed into the antebrachiocarpal joint. The peak mean plasma gentamicin concentration (8.30 micrograms/ml) after IV administration was significantly (P less than 0.05) greater than that (0.69 microgram/ml) after IA administration of gentamicin and that (0.55 microgram/ml) after administration of gentamicin buffered with sodium bicarbonate. Gentamicin concentration greater than a therapeutic concentration was not attained in the plasma after IA administration of buffered or unbuffered gentamicin. The peak mean synovial fluid concentration (1,828 micrograms/ml) after IA administration of unbuffered gentamicin was significantly (P less than 0.05) greater than that (2.53 micrograms/ml) after IV administration and significantly (P less than 0.05) less than that (5,720 micrograms/ml) after simultaneous IV and IA administration. The peak mean synovial fluid concentration after IA administration of buffered gentamicin, with and without simultaneous IV administration (2,128 and 2,680 micrograms/ml, respectively), was not significantly different than that after IA treatment with unbuffered gentamicin. Mean synovial fluid concentration did not differ significantly between groups after IA administration of gentamicin in any combination at postinjection hours 8, 12, and 24, but remained significantly (P less than 0.05) greater than that at the same times after IV administration.(ABSTRACT TRUNCATED AT 250 WORDS)
在静脉注射(2.2毫克/千克体重)、关节内注射(IA;150毫克)以及同时进行静脉注射和关节内注射后,对正常成年马的血浆和滑液中的庆大霉素浓度进行了24小时的定期测量。庆大霉素还用碳酸氢钠(3毫当量)进行了缓冲,然后进行关节内注射以及同时进行静脉注射和关节内注射。通过置于腕关节的留置导管获取滑液样本。静脉注射后庆大霉素的血浆平均峰值浓度(8.30微克/毫升)显著高于(P<0.05)关节内注射庆大霉素后的浓度(0.69微克/毫升)以及用碳酸氢钠缓冲后注射庆大霉素的浓度(0.55微克/毫升)。关节内注射缓冲或未缓冲庆大霉素后,血浆中未达到高于治疗浓度的庆大霉素浓度。未缓冲庆大霉素关节内注射后的滑液平均峰值浓度(1828微克/毫升)显著高于(P<0.05)静脉注射后的浓度(2.53微克/毫升),且显著低于(P<0.05)同时进行静脉注射和关节内注射后的浓度(5720微克/毫升)。缓冲庆大霉素关节内注射后(无论是否同时进行静脉注射)的滑液平均峰值浓度(分别为2128和2680微克/毫升)与未缓冲庆大霉素关节内注射后的浓度无显著差异。在注射后8、12和24小时,无论庆大霉素以何种组合进行关节内注射,各实验组的滑液平均浓度之间均无显著差异,但仍显著高于(P<0.05)静脉注射后相同时间的浓度。(摘要截选至250字)